Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Carthera logo — Advanced Brain Therapy

Carthera

Advanced Brain Therapy

Founded 2010 France France 35 employees Series B Total: $71.30M Biotechnology, Health Care +2

General Information

Company Name Carthera
Founded Year 2010
Location France France
Employees 35
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Carthera. To contact Carthera, visit carthera.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Carthera compare?

A PDF of Carthera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Carthera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Carthera

Carthera is a French medtech startup founded in 2010, specializing in advanced brain therapy. The company has developed the SonoCloud, a proprietary device that utilizes ultrasound to temporarily increase the permeability of blood vessels in the brain. This breakthrough technology aims to enhance the therapeutic efficacy of both new and existing therapies for treating a wide range of severe brain disorders, including oncology indications (such as glioblastoma and brain metastasis) as well as neurodegenerative diseases like Alzheimer's Disease and ALS. Carthera's innovative products are currently in clinical or preclinical evaluation and have not yet received FDA or CE approval. The company recently secured a significant €4.50M Series B investment on 11 December 2023, with the backing of notable investors including Supernova Invest, Unorthodox Ventures, Saint-Genys, and BOUSCAS. The startup's focus on cutting-edge medical devices for treating severe brain disorders presents an exciting opportunity for investors looking to support groundbreaking advancements in the biotechnology and healthcare industries.

Business keywords: Medical Device Innovation, Neurotechnology, Ultrasound Therapy, Brain Disorder Treatment, Biomedical Engineering, Clinical-stage Medtech, Therapeutic Ultrasound, Neuro-oncology, Neurosurgical Devices, Blood-Brain Barrier Technology

Services & Products

Development of innovative ultrasound-based medical devices for the treatment of severe brain disorders
especially focused on glioblastoma and CNS diseases.

Target Customers

Patients with severe brain disorders such as glioblastoma brain metastases and Alzheimer’s Disease healthcare professionals specializing in neuro-oncology and biopharmaceutical companies seeking innovative drug delivery solutions for brain diseases.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €4.50M 4
Supernova Invest Unorthodox Ventures
Supernova Invest, Unorthodox Ventures +2
11 Dec 2023
Series B €37.50M 4
European Innovation Council Panakes Partners Relyens Innovation Santé
European Innovation Council, Panakes Partners +2
27 Jun 2023
Grant €2.00M 1
European Innovation Council
European Innovation Council
14 Sep 2020
Venture Round €10.50M 1
European Innovation Council
European Innovation Council
14 Sep 2020
Series B €9.00M 4
Panakes Partners Supernova Invest
Panakes Partners, Supernova Invest +2
12 Dec 2018
Grant €5.70M -
12 Oct 2016
Series A €2.10M -
13 Apr 2015
Seed Round Undisclosed 1
AGORANOV
AGORANOV
01 Dec 2010

Latest News

View All
Carthera secures additional €4.5M for innovative medtech to treat brain disorders — Tech
Carthera secures additional €4.5M for innovative medtech to treat brain disorders
Tech Jan 23, 2024

Carthera Alternatives & Competitors

View All Alternatives
Carthera vs
Cordance Medical
Cordance Medical United States

Non-invasive therapy delivery system for central nervous system diseases

Seed
10 employees
Health Care, Health and Wellness
Compare Carthera vs Cordance Medical
Carthera vs
ABL Bio Inc.
ABL Bio Inc. Korea South

A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseas...

IPO
64 employees
Biotechnology, Health Care
Compare Carthera vs ABL Bio Inc.
Carthera vs
CorTec
CorTec Germany

Communicating with the Nervous System - for the Cure of Disease

Grant
67 employees
Health Care, Medical Devices
Also compare with: Carthera vs NeuroVigil, Inc. NeuroVigil, Inc. View all alternatives

FAQ About Carthera

Advanced Brain Therapy
Carthera was founded in 2010.
Carthera is headquartered in France.
Carthera operates in Biotechnology, Health Care, Health and Wellness and Medical Devices. Its work centres on Medical Device Innovation, Neurotechnology, Ultrasound Therapy and Brain Disorder Treatment. Its customers include Patients with severe brain disorders such as glioblastoma, brain metastases and and Alzheimer’s Disease.
Carthera has approximately 35 employees.
Carthera has completed 8 funding rounds, raising a total of $71.30M. The latest funding stage is Series B.
Carthera offers: Development of innovative ultrasound-based medical devices for the treatment of severe brain disorders, especially focused on glioblastoma and CNS diseases..
Top alternatives and competitors to Carthera include Cordance Medical, ABL Bio Inc., CorTec, Theraclion, Monteris Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Carthera and Cordance Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Carthera, https://bouncewatch.com/company/carthera, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes